U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
192991192991Irofulven in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal CancerCompletedNo Results AvailableFallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity CancerDrug: irofulvenhttps://ClinicalTrials.gov/show/NCT00019552
192992192992Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney CancerCompletedNo Results AvailableStage IV Renal Cell Cancer|Recurrent Renal Cell CancerDrug: bevacizumab|Drug: thalidomidehttps://ClinicalTrials.gov/show/NCT00019539
192993192993Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or LymphomasCompletedNo Results AvailableColorectal Cancer|Esophageal Cancer|Extrahepatic Bile Duct Cancer|Gallbladder Cancer|Liver Cancer|Lung Cancer|Lymphoma|Pancreatic Cancer|Small Intestine Cancer|Unspecified Adult Solid Tumor, Protocol SpecificDrug: fluorouracil|Drug: gemcitabine hydrochloride|Drug: leucovorin calciumhttps://ClinicalTrials.gov/show/NCT00019513
192994192994Raloxifene in Preventing Breast Cancer in Premenopausal WomenCompletedNo Results AvailableBreast CancerDrug: raloxifene|Procedure: evaluation of cancer risk factorshttps://ClinicalTrials.gov/show/NCT00019500
192995192995Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic MelanomaCompletedNo Results AvailableMelanoma (Skin)Biological: aldesleukin|Biological: gp209-2M antigen|Biological: incomplete Freund's adjuvanthttps://ClinicalTrials.gov/show/NCT00019487
192996192996Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract CancerActive, not recruitingNo Results AvailableExtrahepatic Bile Duct Cancer|Gastric Cancer|Gastrointestinal Carcinoid Tumor|Liver Cancer|Pancreatic Cancer|Small Intestine CancerBiological: filgrastim|Biological: recombinant interferon alfa|Drug: fluorouracil|Drug: hydroxyureahttps://ClinicalTrials.gov/show/NCT00019474
192997192997Carboxyamidotriazole in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNo Results AvailableFallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity CancerDrug: carboxyamidotriazole|Drug: chemotherapyhttps://ClinicalTrials.gov/show/NCT00019461
192998192998Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic MelanomaCompletedNo Results AvailableStage IV Melanoma|Recurrent MelanomaDrug: gp100 antigen|Drug: interleukin-2https://ClinicalTrials.gov/show/NCT00019448
192999192999LMB-9 Immunotoxin in Treating Patients With Advanced Solid TumorsCompletedNo Results AvailableBladder Cancer|Breast Cancer|Colorectal Cancer|Esophageal Cancer|Gastric Cancer|Lung Cancer|Pancreatic CancerBiological: LMB-9 immunotoxinhttps://ClinicalTrials.gov/show/NCT00019435
193000193000Lobradimil and Carboplatin in Treating Children With Brain TumorsCompletedNo Results AvailableBrain and Central Nervous System TumorsDrug: carboplatin|Drug: lobradimilhttps://ClinicalTrials.gov/show/NCT00019422
193001193001Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic LeukemiaWithdrawnNo Results AvailableLeukemiaDrug: asparaginase|Drug: cyclophosphamide|Drug: cytarabine|Drug: daunorubicin hydrochloride|Drug: mercaptopurine|Drug: methotrexate|Drug: prednisone|Drug: therapeutic hydrocortisone|Drug: vincristine sulfate|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00019409
193002193002flt3L With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma or Renal Cell CancerCompletedNo Results AvailableStage IV Melanoma|Stage IV Renal Cell Cancer|Recurrent Renal Cell Cancer|Recurrent MelanomaDrug: flt3 ligand|Drug: gp100 antigen|Drug: MART-1 antigen|Drug: Montanide ISA-51|Drug: tyrosinase peptidehttps://ClinicalTrials.gov/show/NCT00019396
193003193003Vaccine Therapy in Treating Patients With Recurrent or Refractory Metastatic MelanomaCompletedNo Results AvailableMelanoma (Skin)Biological: aldesleukin|Biological: incomplete Freund's adjuvant|Biological: sargramostim|Biological: tyrosinase peptide|Biological: tyrosinase-related protein-1https://ClinicalTrials.gov/show/NCT00019383
193004193004Interleukin-2 Plus Activated White Blood Cells in Treating Patients With Cancer That Has Not Responded to Chemotherapy or Radiation TherapyCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificBiological: aldesleukin|Biological: therapeutic autologous lymphocytes|Biological: therapeutic tumor infiltrating lymphocyteshttps://ClinicalTrials.gov/show/NCT00019357
193005193005Flavopiridol in Treating Patients With Refractory CancerCompletedNo Results AvailableLymphoma|Prostate Cancer|Small Intestine Cancer|Unspecified Adult Solid Tumor, Protocol SpecificDrug: alvocidibhttps://ClinicalTrials.gov/show/NCT00019344
193006193006Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsCompletedNo Results AvailableColorectal Cancer|Endometrial Cancer|Head and Neck Cancer|Liver Cancer|Lung Cancer|Melanoma (Skin)|Pancreatic Cancer|Testicular Germ Cell Tumor|Unspecified Adult Solid Tumor, Protocol SpecificBiological: aldesleukin|Biological: ras peptide cancer vaccine|Biological: sargramostim|Drug: DetoxPChttps://ClinicalTrials.gov/show/NCT00019331
193007193007Depsipeptide in Treating Patients With Solid TumorsCompletedNo Results AvailableLymphomaDrug: romidepsinhttps://ClinicalTrials.gov/show/NCT00019318
193008193008Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV InfectionCompletedNo Results AvailableSarcomaDrug: cidofovirhttps://ClinicalTrials.gov/show/NCT00019240
193009193009Monoclonal Antibody Therapy in Treating Patients With LeukemiaCompletedNo Results AvailableLymphoma|Radiation ToxicityDrug: pentetic acid calcium|Radiation: yttrium Y 90 daclizumabhttps://ClinicalTrials.gov/show/NCT00019227
193010193010Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic MelanomaCompletedNo Results AvailableMelanoma (Skin)Biological: MART-1 antigen|Biological: aldesleukin|Biological: gp100 antigenhttps://ClinicalTrials.gov/show/NCT00019214
193011193011Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung CancerCompletedNo Results AvailableHead and Neck Cancer|Lung CancerOther: cytology specimen collection procedure|Other: immunohistochemistry staining method|Other: sputum cytology|Procedure: bronchoscopic and lung imaging studies|Procedure: bronchoscopy|Procedure: comparison of screening methods|Procedure: endoscopic biopsyhttps://ClinicalTrials.gov/show/NCT00019201
193012193012Interleukin-12 in Treating Patients With AIDS-Related Kaposi's SarcomaCompletedNo Results AvailableEpidemic Kaposi's Sarcoma|Recurrent Kaposi's SarcomaDrug: interleukin-12https://ClinicalTrials.gov/show/NCT00019188
193013193013Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Recurrent Metastatic MelanomaCompletedNo Results AvailableMelanoma (Skin)Biological: aldesleukin|Biological: fowlpox virus vaccine vector|Biological: gp100 antigenhttps://ClinicalTrials.gov/show/NCT00019175
193014193014Gene Therapy and Biological Therapy in Treating Patients With Ovarian Epithelial CancerCompletedNo Results AvailableOvarian CancerBiological: MOv-gamma chimeric receptor gene|Biological: aldesleukin|Biological: therapeutic allogeneic lymphocyteshttps://ClinicalTrials.gov/show/NCT00019136
193015193015Thalidomide in Treating Patients With HIV-Associated Kaposi's SarcomaCompletedNo Results AvailableSarcomaDrug: thalidomidehttps://ClinicalTrials.gov/show/NCT00019123
193016193016Vaccine Therapy in Treating Patients With Advanced or Recurrent CancerCompletedNo Results AvailableAnal Cancer|Cervical Cancer|Esophageal Cancer|Head and Neck Cancer|Penile Cancer|Vulvar CancerBiological: human papillomavirus 16 E7 peptide|Biological: synthetic human papillomavirus 16 E6 peptidehttps://ClinicalTrials.gov/show/NCT00019110
193017193017Vaccine Therapy in Treating Patients With Multiple MyelomaCompletedNo Results AvailableStage II Multiple Myeloma|Stage III Multiple Myeloma|Refractory Plasma Cell NeoplasmDrug: autologous tumor cell vaccine|Drug: keyhole limpet hemocyanin|Drug: melphalan|Drug: sargramostimhttps://ClinicalTrials.gov/show/NCT00019097
193018193018Vaccine Therapy and Biological Therapy in Treating Patients With Advanced CancerCompletedNo Results AvailableBreast Cancer|Cervical Cancer|Colorectal Cancer|Lung Cancer|Ovarian Cancer|Pancreatic CancerBiological: aldesleukin|Biological: mutant p53 peptide pulsed dendritic cell vaccine|Biological: ras peptide cancer vaccine|Biological: sargramostim|Biological: therapeutic autologous lymphocytes|Biological: therapeutic tumor infiltrating lymphocyteshttps://ClinicalTrials.gov/show/NCT00019084
193019193019Chemotherapy Followed by Radiation Therapy in Treating Patients With Malignant GliomaCompletedNo Results AvailableBrain and Central Nervous System TumorsDrug: chemotherapy|Drug: cladribine|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00019071
193020193020Radiation Therapy in Treating Patients With GlioblastomaCompletedNo Results AvailableBrain and Central Nervous System TumorsDrug: chemotherapy|Drug: hydroxyurea|Drug: pentoxifylline|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00019058

* Görseller ve İçerik tekif hakkına sahip olabilir